Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
452.00
376.02
403.49
399.45
362.19
369.89
335.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
452.00
376.02
403.49
399.45
362.19
369.89
335.71
Raw Material Cost
315.21
243.77
303.24
265.72
225.75
240.59
216.48
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.78
0.15
1.42
1.04
0.00
0.38
1.01
Selling and Distribution Expenses
88.63
75.32
79.09
106.82
95.73
71.39
68.94
Other Expenses
3.05
2.64
2.01
2.80
3.32
3.30
2.86
Total Expenditure (Excl Depreciation)
435.09
345.62
403.82
401.61
354.65
345.37
315.06
Operating Profit (PBDIT) excl Other Income
16.9
30.4
-0.3
-2.2
7.5
24.5
20.7
Other Income
11.65
10.94
26.83
3.63
20.96
12.15
15.14
Operating Profit (PBDIT)
70.38
84.12
34.38
39.93
68.80
83.58
85.29
Interest
0.78
0.15
1.42
1.04
0.00
0.38
1.01
Exceptional Items
0.09
0.76
-0.47
0.67
-0.38
0.61
-0.30
Gross Profit (PBDT)
136.79
132.25
100.25
133.73
136.44
129.29
119.23
Depreciation
47.43
47.43
43.37
43.37
47.35
47.35
67.77
Profit Before Tax
22.26
37.29
-10.87
-3.80
21.08
36.46
19.76
Tax
1.09
3.79
-9.78
-6.82
-1.95
3.28
-11.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.18
33.77
2.67
3.70
26.44
30.40
33.63
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28.18
33.77
2.67
3.70
26.44
30.40
33.63
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.18
-0.58
-0.20
-0.41
-0.61
-0.62
5.71
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
28.37
33.19
2.47
3.29
25.83
29.78
39.35
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,003.34
2,987.60
2,954.21
2,955.78
2,952.11
2,970.50
2,939.83
Earnings per share (EPS)
0.07
0.09
0.01
0.01
0.07
0.08
0.09
Diluted Earnings per share
0.07
0.09
0.01
0.01
0.07
0.08
0.09
Operating Profit Margin (Excl OI)
2.5%
6.85%
-8.88%
-1.77%
0.14%
6.51%
0.71%
Gross Profit Margin
15.42%
22.53%
8.05%
9.91%
18.89%
22.66%
26.07%
PAT Margin
6.24%
8.98%
0.66%
0.93%
7.3%
8.22%
10.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 20.21% vs -6.82% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -14.46% vs 1,228.00% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -19.81% vs 863.16% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 300.00% vs -85.71% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of MedicalSystem Biotechnology Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
452.00
0
452.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
452.00
0
452.00
Raw Material Cost
315.21
0
315.21
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.78
0
0.78
Selling and Distribution Expenses
88.63
0
88.63
Other Expenses
3.05
0.00
3.05
Total Expenditure (Excl Depreciation)
435.09
0
435.09
Operating Profit (PBDIT) excl Other Income
16.91
0.00
16.91
Other Income
11.65
0
11.65
Operating Profit (PBDIT)
70.38
0
70.38
Interest
0.78
0
0.78
Exceptional Items
0.09
0
0.09
Gross Profit (PBDT)
136.79
0
136.79
Depreciation
47.43
0
47.43
Profit Before Tax
22.26
0
22.26
Tax
1.09
0
1.09
Provisions and contingencies
0
0
0.00
Profit After Tax
28.18
0
28.18
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
28.18
0
28.18
Share in Profit of Associates
0
0
0.00
Minority Interest
0.18
0
0.18
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.37
0
28.37
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,003.34
0
3,003.34
Earnings per share (EPS)
0.07
0
0.07
Diluted Earnings per share
0.07
0
0.07
Operating Profit Margin (Excl OI)
2.50%
0%
0.00
2.50%
Gross Profit Margin
15.42%
0%
0.00
15.42%
PAT Margin
6.24%
0%
0.00
6.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 45.20 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 20.21% vs -6.82% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 24.79% vs -22.54% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.84 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -14.46% vs 1,228.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 10.08% vs -74.28% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.87 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -19.81% vs 863.16% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 22.80% vs -63.54% in Jun 2025
Quarterly - Interest
Interest 0.08 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 300.00% vs -85.71% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.00% vs -100.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.50%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
